[1]
|
杨国林, 易何娟. 血清CRP、PCT、IL-17对慢性阻塞性肺疾病稳定期患者急性发作的预测作用[J]. 检验医学与临床, 2024, 21(7): 999-1002.
|
[2]
|
Tang, L., Shi, S., Wang, B., Liu, L., Yang, Y., Sun, X., et al. (2021) Effect of Urban Air Pollution on CRP and Coagulation: A Study on Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. BMC Pulmonary Medicine, 21, Article No. 296. https://doi.org/10.1186/s12890-021-01650-z
|
[3]
|
Butler, C.C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., et al. (2019) C-reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New England Journal of Medicine, 381, 111-120. https://doi.org/10.1056/nejmoa1803185
|
[4]
|
Al-Hasan, M.N. and Al-Jaghbeer, M.J. (2020) Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What Is Their Current Role in Older Patients? Drugs & Aging, 37, 627-633. https://doi.org/10.1007/s40266-020-00786-7
|
[5]
|
Aslani, M., Amani, M., Moghadas, F. and Ghobadi, H. (2022) Adipolin and IL-6 Serum Levels in Chronic Obstructive Pulmonary Disease. Advances in Respiratory Medicine, 90, 391-398. https://doi.org/10.3390/arm90050049
|
[6]
|
Huang, H., Huang, X., Zeng, K., Deng, F., Lin, C. and Huang, W. (2021) Interleukin-6 Is a Strong Predictor of the Frequency of COPD Exacerbation within 1 Year. International Journal of Chronic Obstructive Pulmonary Disease, 16, 2945-2951. https://doi.org/10.2147/copd.s332505
|
[7]
|
Aslani, M.R., Ghazaei, Z. and Ghobadi, H. (2020) Correlation of Serum Fatty Acid Binding Protein-4 and Interleukin-6 with Airflow Limitation and Quality of Life in Stable and Acute Exacerbation of COPD. Turkish Journal of Medical Sciences, 44, 337-345. https://doi.org/10.3906/sag-1909-9
|
[8]
|
Bradford, E., Jacobson, S., Varasteh, J., Comellas, A.P., Woodruff, P., O’Neal, W., et al. (2017) The Value of Blood Cytokines and Chemokines in Assessing COPD. Respiratory Research, 18, Article No. 180. https://doi.org/10.1186/s12931-017-0662-2
|
[9]
|
Feng, Y. and Liu, E. (2022) Detection of Respiratory Viruses and Expression of Inflammatory Cytokines in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease in Mongolia China. Brazilian Journal of Biology, 82, e231134. https://doi.org/10.1590/1519-6984.231134
|
[10]
|
李建英, 刘远程, 潘杨. 8-异前列腺素F2α和白细胞介素-17预测慢性阻塞性肺疾病稳定期患者急性发作的作用[J]. 医学研究生学报, 2022, 35(8): 863-867.
|
[11]
|
Shen, S. and Xiao, Y. (2023) Association between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 18, 2289-2303. https://doi.org/10.2147/COPD.s413912
|
[12]
|
Yao, Y., Zhou, J., Diao, X. and Wang, S. (2019) Association between Tumor Necrosis Factor-Α and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Therapeutic Advances in Respiratory Disease, 13, 1-17. https://doi.org/10.1177/1753466619866096
|
[13]
|
Chiang, C., Chuang, C. and Liu, S. (2013) Transforming Growth Factor-Β1 and Tumor Necrosis Factor-Α Are Associated with Clinical Severity and Airflow Limitation of COPD in an Additive Manner. Lung, 192, 95-102. https://doi.org/10.1007/s00408-013-9520-2
|
[14]
|
Mohan, A., Arora, S., Uniyal, A., Poulose, R., Luthra, K., Pandey, R., et al. (2017) Evaluation of Plasma Leptin, Tumor Necrosis Factor-Α, and Prealbumin as Prognostic Biomarkers during Clinical Recovery from Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Lung India, 34, 3-8. https://doi.org/10.4103/0970-2113.197101
|
[15]
|
Celli, B.R., Anderson, J.A., Brook, R., Calverley, P., Cowans, N.J., Crim, C., et al. (2019) Serum Biomarkers and Outcomes in Patients with Moderate COPD: A Substudy of the Randomised SUMMIT Trial. BMJ Open Respiratory Research, 6, e000431. https://doi.org/10.1136/bmjresp-2019-000431
|
[16]
|
Duvoix, A., Dickens, J., Haq, I., Mannino, D., Miller, B., Tal-Singer, R., et al. (2012) Blood Fibrinogen as a Biomarker of Chronic Obstructive Pulmonary Disease: Table 1. Thorax, 68, 670-676. https://doi.org/10.1136/thoraxjnl-2012-201871
|
[17]
|
Sun, W., Cao, Z., Ma, Y., Wang, J., Zhang, L. and Luo, Z. (2022) Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease, 17, 1299-1310. https://doi.org/10.2147/COPD.s361929
|
[18]
|
Mohan, M., Parthasarathi, A., S K, C., Biligere Siddaiah, J. and Mahesh, P.A. (2021) Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus, 13, e16864. https://doi.org/10.7759/cureus.16864
|
[19]
|
Zhou, B., Liu, S., He, D., Wang, K., Wang, Y., Yang, T., et al. (2020) Fibrinogen Is a Promising Biomarker for Chronic Obstructive Pulmonary Disease: Evidence from a Meta-Analysis. Bioscience Reports, 40, BSR20193542. https://doi.org/10.1042/bsr20193542
|
[20]
|
Chen, L., Xu, W., Chen, J., Zhang, H., Huang, X., Ma, L., et al. (2023) Evaluating the Clinical Role of Fibrinogen, D-Dimer, Mean Platelet Volume in Patients with Acute Exacerbation of COPD. Heart & Lung, 57, 54-58. https://doi.org/10.1016/j.hrtlng.2022.08.013
|
[21]
|
Lazovic, B. (2012) Correlation of CRP and Serum Level of Fibrinogen with Severity of Disease in Chronic Obstructive Pulmonary Disease Patients. Medical Archives, 66, 159-160. https://doi.org/10.5455/medarh.2012.66.159-160
|
[22]
|
Fruchter, O., Yigla, M. and Kramer, M.R. (2015) D-Dimer as a Prognostic Biomarker for Mortality in Chronic Obstructive Pulmonary Disease Exacerbation. The American Journal of the Medical Sciences, 349, 29-35. https://doi.org/10.1097/maj.0000000000000332
|
[23]
|
Liu, B.H., Sun, M.X., Zhou, N., et al. (2016) Detection and Study of Plasma D-Dimer Change in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Biological Regulators and Homeostatic Agents, 30, 839-845.
|
[24]
|
Zhang, M., Zhang, J., Zhang, Q., Yang, X., Shan, H., Ming, Z., et al. (2016) D-Dimer as a Potential Biomarker for the Progression of COPD. Clinica Chimica Acta, 455, 55-59. https://doi.org/10.1016/j.cca.2016.01.024
|
[25]
|
Hu, G., Wu, Y., Zhou, Y., Wu, Z., Wei, L., Li, Y., et al. (2016) Prognostic Role of D-Dimer for In-Hospital and 1-Year Mortality in Exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2729-2736. https://doi.org/10.2147/COPD.s112882
|
[26]
|
Zhang, Q., Liu, J., Bai, J., Wang, J., Fu, A., Liu, R., et al. (2023) D-Dimer and Procalcitonin Improve the Sensitivity of BAP-65 Score in Predicting AECOPD Patients Admission to ICU. Clinical Laboratory, 69, 238-245. https://doi.org/10.7754/clin.lab.2022.220343
|
[27]
|
Husebø, G.R., Gabazza, E.C., D’Alessandro Gabazza, C., Yasuma, T., Toda, M., Aanerud, M., et al. (2020) Coagulation Markers as Predictors for Clinical Events in COPD. Respirology, 26, 342-351. https://doi.org/10.1111/resp.13971
|
[28]
|
Zhang, M., Li, Y., Yang, X., Shan, H., Zhang, Q., Ming, Z., et al. (2015) Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients. Inflammation, 39, 625-631. https://doi.org/10.1007/s10753-015-0287-x
|
[29]
|
Zhang, Y., Zhu, Y., Wu, Y., et al. (2014) Serum Cystatin C as a Potential Biomarker for the Evaluation COPD. International Journal of Clinical and Experimental Medicine, 7, 5484-5490.
|
[30]
|
Chai, L., Feng, W., Zhai, C., Shi, W., Wang, J., Yan, X., et al. (2020) The Association between Cystatin C and COPD: A Meta-Analysis and Systematic Review. BMC Pulmonary Medicine, 20, Article No. 182. https://doi.org/10.1186/s12890-020-01208-5
|
[31]
|
Telo, S., Kuluöztürk, M., Deveci, F., Kırkıl, G., Öner, Ö. and Kaman, D. (2018) Serum Cystatin C Levels in COPD: Potential Diagnostic Value and Relation between Respiratory Functions. Journal of Medical Biochemistry, 37, 434-440. https://doi.org/10.1515/jomb-2017-0063
|
[32]
|
Hu, G., Wu, Y., Zhou, Y., Yu, Y., Liang, W. and Ran, P. (2016) Cystatin C as a Predictor of In-Hospital Mortality after Exacerbation of COPD. Respiratory Care, 61, 950-957. https://doi.org/10.4187/respcare.04034
|
[33]
|
Papaporfyriou, A., Bakakos, P., Hillas, G., Papaioannou, A.I. and Loukides, S. (2021) Blood Eosinophils in COPD: Friend or Foe? Expert Review of Respiratory Medicine, 16, 35-41. https://doi.org/10.1080/17476348.2021.2011219
|
[34]
|
Zeiger, R.S., Tran, T.N., Butler, R.K., Schatz, M., Li, Q., Khatry, D.B., et al. (2018) Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice, 6, 944-954.e5. https://doi.org/10.1016/j.jaip.2017.10.004
|
[35]
|
Tashkin, D.P. and Wechsler, M.E. (2018) Role of Eosinophils in Airway Inflammation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 13, 335-349. https://doi.org/10.2147/COPD.s152291
|
[36]
|
Kang, H.S., Kim, S.K., Kim, Y.H., Kim, J.W., Lee, S.H., Yoon, H.K., et al. (2021) The Association between Eosinophilic Exacerbation and Eosinophilic Levels in Stable COPD. BMC Pulmonary Medicine, 21, Article No. 74. https://doi.org/10.1186/s12890-021-01443-4
|
[37]
|
MacDonald, M.I., Osadnik, C.R., Bulfin, L., Hamza, K., Leong, P., Wong, A., et al. (2019) Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD. Chest, 156, 92-100. https://doi.org/10.1016/j.chest.2019.02.406
|
[38]
|
Citgez, E., van der Palen, J., van der Valk, P., Kerstjens, H.A.M. and Brusse-Keizer, M. (2021) Stability in Eosinophil Categorisation during Subsequent Severe Exacerbations of COPD. BMJ Open Respiratory Research, 8, e000960. https://doi.org/10.1136/bmjresp-2021-000960
|
[39]
|
Gueçamburu, M. and Zysman, M. (2022) BPCO et éosinophiles. Revue des Maladies Respiratoires, 39, 685-697. https://doi.org/10.1016/j.rmr.2022.08.005
|
[40]
|
Han, Z., Hu, H., Yang, P., Li, B., Liu, G., Pang, J., et al. (2022) White Blood Cell Count and Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study. Computers in Biology and Medicine, 151, Article ID: 106187. https://doi.org/10.1016/j.compbiomed.2022.106187
|
[41]
|
Zinellu, A., Zinellu, E., Pau, M.C., Carru, C., Pirina, P., Fois, A.G., et al. (2022) A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 11, Article No. 3365. https://doi.org/10.3390/jcm11123365
|
[42]
|
Lan, C., Su, W., Yang, M., Chen, S. and Wu, Y. (2023) Predictive Role of Neutrophil‐Percentage‐to‐Albumin, Neutrophil‐to‐Lymphocyte and Eosinophil‐to‐Lymphocyte Ratios for Mortality in Patients with COPD: Evidence from NHANES 2011-2018. Respirology, 28, 1136-1146. https://doi.org/10.1111/resp.14589
|
[43]
|
Emami Ardestani, M. and Alavi‐Naeini, N. (2020) Evaluation of the Relationship of Neutrophil‐to-Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio with In‐Hospital Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The Clinical Respiratory Journal, 15, 382-388. https://doi.org/10.1111/crj.13312
|
[44]
|
Singh, B., Dutta, V., Singh, S. and Pundit, P. (2024) Diagnostic Insights from Chemometric Analysis of Hemogram Inflammatory Indexes in Male Smokers with and without Asthma or Chronic Obstructive Pulmonary Disease. International Journal of Laboratory Hematology, 46, 627-636. https://doi.org/10.1111/ijlh.14264
|
[45]
|
Gutta, L., M, S. and Ahmed, T. (2022) NLR and PLR Ratios—Accessible and Affordable Predictors of Disease Severity in COPD. Journal of the Association of Physicians of India, 70, 11-12.
|
[46]
|
Sakurai, K., Chubachi, S., Irie, H., Tsutsumi, A., Kameyama, N., Kamatani, T., et al. (2018) Clinical Utility of Blood Neutrophil-Lymphocyte Ratio in Japanese COPD Patients. BMC Pulmonary Medicine, 18, Article No. 65. https://doi.org/10.1186/s12890-018-0639-z
|
[47]
|
Ellingsen, J., Janson, C., Bröms, K., Lisspers, K., Ställberg, B., Högman, M., et al. (2021) Neutrophil-to-Lymphocyte Ratio, Blood Eosinophils and COPD Exacerbations: A Cohort Study. ERJ Open Research, 7, Article ID: 00471-2021. https://doi.org/10.1183/23120541.00471-2021
|
[48]
|
El-Gazzar, A.G., Kamel, M.H., Elbahnasy, O.K.M. and El-Naggar, M.E. (2019) Prognostic Value of Platelet and Neutrophil to Lymphocyte Ratio in COPD Patients. Expert Review of Respiratory Medicine, 14, 111-116. https://doi.org/10.1080/17476348.2019.1675517
|
[49]
|
Shao, S., Zhang, Z., Feng, L., Liang, L. and Tong, Z. (2023) Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing. International Journal of Chronic Obstructive Pulmonary Disease, 18, 1783-1802. https://doi.org/10.2147/COPD.s416869
|
[50]
|
Alupo, P., Katagira, W., Mukunya, D., et al. (2024) The Neutrophil-to-Lymphocyte Ratio as a Predictor of Acute Exacerbations among Patients with COPD in Uganda. Chronic Obstructive Pulmonary Disease, 11, 187-195.
|
[51]
|
Gómez-Rosero, J.A., Cáceres-Galvis, C., Ascuntar, J., Atencia, C., Vallejo, C.E. and Jaimes, F. (2021) Biomarkers as a Prognostic Factor in COPD Exacerbation: A Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease, 18, 325-332. https://doi.org/10.1080/15412555.2021.1922370
|